Abstract
To date, there are limited data on clinical manifestations and perinatal outcomes following infection with COVID-19 during pregnancy or the postpartum period. There is no evidence that pregnant women have different signs and / or symptoms or are at higher risk of serious illness. There is still no evidence of mother-to-child transmission when infection develops in the third trimester, based on negative samples from amniotic fluid, cord blood, vaginal discharge, throat swabs of newborns, or breast milk.
Users
Please
log in to take part in the discussion (add own reviews or comments).